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Abstract 
Purpose: To investigate the effect of Camellia nitidissima C. W. Chi extract (CNCE) on apoptosis and 
proliferation in A549 human lung cancer cells. 
Methods: Inverted microscope was used to examine morphological changes in A549 cells after 
exposure to CNCE. Trypan blue staining of living cells was applied to construct the cell growth curve 
after treatment with varying concentrations of CNCE. The influence of CNCE on cell proliferation, 
apoptosis and cell cycle were determined by MTT assay. The protein expressions of key apoptosis-
related enzymes were evaluated by immuno-cytochemical method.   
Results: CNCE inhibited the growth of A549 lung cancer cells at the concentration range of 20 - 160 
μg/mL. Flow cytometry showed that CNCE induced apoptosis in the A549 cells. The proportion of cells 
in G0/G1-phase increased significantly (p < 0.01), while the proportion of cells in S-phase and G2/M-
phase decreased correspondingly, indicating that the cells were in G0/G1-phase arrest. Cell cycle arrest 
and apoptosis-inducing effect gradually increased with increase in CNCE concentration. With increasing 
concentrations of CNCE, there were significant increases in the expressions of caspase-3 (p < 0.05), 
caspase-8 (p < 0.01) and caspase-9 (p < 0.05), and significant decreases in Ki-67 (p < 0.01) and p21 
ras protein (p < 0.01). 
Conclusion: CNCE exerts significant inhibitory effect on the proliferation of A549 lung cancer cells, and 
therefore can potentially be developed for the treatment of lung cancer. 
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 The morbidity and mortality from lung cancer 
account for 13 % and 19.4 % respectively, 
worldwide [1].  Lung cancer is classified into 
small cell lung carcinoma (SCLC) and non-small 
cell lung carcinoma (NSCLC). The latter 
(NSCLC) accounts for most (about 80 %) lung 
tumors. At present, early-stage NSCLC is treated 
by surgical intervention, while mid-late NSCLC is 
treated with radiotherapy and chemotherapy. 
Although effective for some patients in the short 
run, radiotherapy and chemotherapy are 
associated with adverse effects, toxicity, high 
recurrence of tumor and poor prognosis [2]. 
Therefore, it is necessary to reduce the side 
effects of chemotherapy drugs by searching for 
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more effective anticancer drugs with lower 
toxicity. This has been a major challenge to 
medical science. 
 
Camellia nitidissima C. W. Chi is a very valuable 
plant in Guangxi of China. Studies have shown 
that Camellia nitidissima C. W. Chi has anti-
aging, blood pressure-lowering, hypoglycemic 
and immunity-enhancing properties [3]. It also 
has antioxidant activity [4], and exerts cytotoxic 
effects on various malignant tumors [5,6]. This 
study was carried out to investigate the effect of 
Camellia nitidissima C. W. Chi extract on 







Human lung cancer cell line (A549) was 
purchased from the Institute of Basic Medical 
Sciences, Chinese Academy of Medical 
Sciences. Camellia nitidissima C. W. Chi was 
obtained from Guangxi, China. RPMI1640 culture 
medium was a product of GIBCO Company, 
USA). Calf serum and phosphate buffer solution 
(PBS, American hyclone); dimethylthiozol-2-yl-
2,5-diphenyl tetrazolium bromide (MTT), dimethyl 
sulfoxide (DMSO), propidium iodide (PI) and 
trypsin were obtained from Sigma-Aldrich 
(America). Caspase-3, caspase-8, caspase-9, Ki-
67, bcl-2 p21 ras monoclonal antibodies, and SP 
generic kits were purchased from American 
NeoMarkers (San Francisco, USA) . 
 
Samples of Camellia nitidissima C. W. Chi were 
collected from Guiyang City, Guangxi Province, 
China in September 2016. Taxonomic 
identification of the plant was done by Professor 
Ye Hu of Southern Medical University in China. A 
voucher specimen (no. CNCE 20160912) was 
deposited in the herbarium of College of 
Pharmacy, Southern Medical University, China 




The instruments used were 96-well plates 
(Corning Company, Wuhan, China); automatic 
CO2 incubator (DuPont Company of America 
Napoc6100); 450 enzyme standard instrument 
(American BioRad); inverted microscope 
(Olympus CX41-32C02, Japan); 4 % hope blue 
mother liquor (Japanese BigWood Industrial Co., 
Ltd.) and LKB- ultrathin sections machine 
(Sweden). Others were YZ-1450 laminar flow 
ultranet work station (Suzhou Purification 
Equipment Company, Suzhou, China); elite flow 
cytometer (Coulter, USA); blood cell counting 
plate; vacuum drying oven (DZF-6021 type, 
Shanghai Fine Macro Experiment Equipment 
Limited), and ultrasonic cleaner CQ25-12 type 
(Shanghai Scientz Biotechnology Research 
Institute). 
 
Preparation of CNCE 
 
Dry leaves of Camellia nitidissima C. W. Chi (50 
g) were ground and extracted three times by 
refluxing with 95 % ethanol, each time for 2 h. 
The extracts were pooled and concentrated 




The A549 cells were cultured in RPMI-1640 
medium (Gibco, Rockville, MD) containing 10 % 
fetal bovine serum (v/v) (FBS; Hyclone, Logan, 
UT) and 1% Penicillin Streptomycin (100 U/mL 
and 100 µg/mL, respectively) at 37 °C in a 
humidified atmosphere containing 5 % CO2, with 
0.25 % trypsin digestion batches. The logarithmic 
phase of the cells were used for the study. 
 
Drug sensitivity test 
 
Cells at the logarithmic growth phase (in 
RPMI1640 medium) at a concentration of 1.0 × 
105 cells/mL of cell suspension, were seeded in 
48-well plates and cultured at 37 oC for 24 h, until 
the cells became adherent. CNCE at different 
final concentrations (30, 60, 120, 240 μg/mL) 
were added to different wells, and the wells were 
for different periods (24, 48 and 72 h) at 37 oC. A 
well containing 20 μg/mL cisplatin served as 
positive control, while another well containing 
saline in place of CNCE served as negative 
control. 
 
Cell morphology assay  
 
A suspension of A549 cells at the logarithmic 
growth phase in RPMI 164 medium was adjusted 
to a concentration of 1.0×105 cells/mL in a 48-
well culture plate, and cultured for 24 h at 37 oC 
to achieve adherence. The wells were grouped 
into two. One group (experimental group) 
received different concentrations of CNCE (62.5, 
125 or 250 ug/mL) in the culture medium, while 
the other group (control group) received 0.04 % 
DMSO in place of CNCE. The cells were 
observed under inverted microscope after 24, 48 
and 72 h for changes in cell size, cell membrane 
and nucleus. 
 
Growth curve and doubling time (TD) of A549 
lung cancer cells 
 
The  A549  cells at logarithmic growth phase at a  
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concentration of 1 × 104 cells/mL were seeded in 
24-well plates. One milliliter was taken from each 
of three wells at the same time point daily, and 
digested. The number of cells per well was 
counted using a hemocytometer, and the mean 
number of cells was determined. Counting was 
done for 8 days. A growth curve was plotted with 
mean cell count as vertical axis, and time as 
horizontal axis. Doubling time (TD) for the human 
lung cancer A549 cells was calculated using Eq 
1. 
 
TD = t{log2/(logNt - logNo)} ………………. (1) 
 
where t is time interval, while No, and Nt are the 
initial mean count and mean count after time t, 
respectively. 
 
MTT assay  
 
A suspension of the A549 cells (0.2 mL) at 
logarithmic phase was seeded in a 96-well plate 
with each well containing 5×103 cells, and 
cultured overnight for cell adhesion. In the 
experimental group, the original culture medium 
was drained, and replaced with different 
concentrations of freshly-prepared CNCE (one 
concentration in 24 wells, and 6 wells per group). 
The wells of the control group medium contained 
0.04 % DMSO, while wells without cells served 
as blank control.  
 
All wells were incubated for 24, 48, 72 and 96 h 
at 37 oC in a humid atmosphere containing 5 % 
CO2. The supernatant was discarded, and 20 μL 
of MTT solution (5 g/L) was added to each well 
and incubated at 37 oC for 4 h. Then, the 
supernatant was carefully removed by suction, 
and 150 μL DMSO was added to each well to 
dissolve the crystals. The absorbance of each 
solution was read at 490 nm against blank 
control, and the results were used for calculating 




A suspension of 549 human lung cancer cells 
(5.0 × 104 cells/mL) at logarithmic growth phase 
was seeded in 24-well plates (100 μL in each 
well), and cultured in RPMI 1640 medium for 24 
h for adherence. Thereafter, CNCE was added to 
a final concentration of 40 μg/mL. Wells in the 
control group contained an equivalent volume of 
normal saline. The plates were cultured at 37 oC 
in an atmosphere of 5 % CO2.  At 24 and 48 h, 
the cells in each group were collected (cell 
number > 1 × 106), washed twice in cold PBS 
(pH 7. 2 - 7. 4), and centrifuged at 1000 rpm for 5 
min. Then, 1 mL of cold precipitation PBS (pH 
7.2 - 7.4) was added to the cell suspension, 
followed by 3 mL of pre-cooled 70 % ethanol. 
 
The cell suspension was kept overnight at 4 oC, 
and then centrifugal at 1000 rpm for 5 min. The 
supernatant was discarded; and the cells were 
washed twice in 1 mL of cold PBS (pH 7.2 - 7.4), 
and centrifuged at 1000 rpm for 5 min. The cell 
count was adjusted to 1 × 106 / mL, and 200 uL 
NaseA was added, followed by incubation in a 37 
oC water bath for 30 min. Iodide C ingot (PI) 
staining fluid 800 µL was added, mixed and kept 
at 4 oC in the dark for 30 min. DNA single 
parameter analysis was carried out to determine 
cell distribution and the proportion of cells in 
G0/D1, S, and G2/M phases, as a function of 





The A549 cells at logarithmic phase were 
digested with 0.25 % trypsin, and 2 × 105 cells 
were seeded into a 6-well plate and cultured 
overnight for cell adhesion. The culture medium 
was removed, and 3mL of CNCE was added to 
different cells to final concentrations of 30, 60, 
120 and 240 μg/mL. Each CNCE concentration 
was replicated in six parallel wells. In the control 
wells, CNCE was replaced with an equivalent 
volume of 0.04 % DMSO. The plates were 
incubated for 24 and 48 h; the glass slides were 
taken out, dried and fixed with 4 % 
paraformaldehyde for 10 min at 4 oC according to 
instructions contained in the operation manual of 
S-P kit. The plates were observed for 
appearance of clear brown granules which is 
indicative of positive cells.  
 
The presence of Bcl-2 and p21 ras in cytoplasm 
is indicative of positive expression; Ki67 tan is 
indicative of positive expression in the nucleus, 
caspase-9 is an index of positive expression in 
the cytoplasm and the nucleus; while caspase-3 
and caspase-8 indicate positive expression in the 
cytoplasm or cytoplasm and nuclei. They are 
expressed less in cells without changes in color, 
or lightly-colored cells. The cells in the CNCE 
plates and control plates were observed at high 
magnification (× 400) in 5 fields, and positive 
cells were counted and expressed as percentage 




All data are expressed as mean ± standard error 
of mean (SEM), and processed using SPSS 16.0 
(SPSS Inc., Illinois, Chicago, USA). They were 
analyzed by one-way analysis of variance 
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(ANOVA) followed by Dunnett’s t-test. P < 0.05 




Effect of CNCE on proliferation of A549 cells 
 
CNCE at different doses significantly inhibited 
the proliferation of A549 cells after 48 h when 
compared with control group (p < 0. 05). The 
inhibitory effect was dose-dependent. These 
results are shown in Table 1. 
 
Table 1: Inhibitory effect of CNCE on the proliferation 







   (%) 
-ve control － 0. 365±0. 003 － 
+ve control 20  0. 047±0. 0022 91. 35±0. 19 
CNCE  30  0. 189±0. 0021 49. 42±0. 22 
 60 0. 186±0. 0041 52. 16±0. 31 
 120  0. 176±0. 0012 53. 24±0. 32 
 240 0. 128±0. 0042 62. 18±0. 20 
-ve = negative, -ve = positive, values are mean ± SEM 
(n = 4); 1p < 0. 05，2p < 0. 01 relative to control 
 
Effect of CNCE on cell morphology  
 
Under the inverted microscope, the control group 
of lung cancer A549 cells grew densely, with 
overlapping clusters, as a long fusiform or 
polygon, without direction and with clear cellular 
edges. On the other hand, A549 cells treated 
with CNCE at concentrations of 10 and 20 ug/mL 
showed reduction in number of cells, and no 
obvious morphological changes. When the 
concentration of CNCE reached 40 ug/mL, the 
cell volume shrank, becoming smaller; and the 
cells were fewer and separated, with many of 
floating particles in the culture medium. At 
concentrations of 160 and 320 ug/mL of CNCE, 
there were very clear and obvious changes in 
cell morphology, and evidence of cell disruption 
and higher cell death. 
 
Growth curve and TD of A549 human lung 
cancer cells  
 
The growth curve of A549 cells is shown in 
Figure 1. Cell proliferation was initially slow 
within the first 48 hours, but thereafter rose 
rapidly and peaked after 6 days, followed by a 
decline on the 7th and 8th days. The value of TD 
obtained was 20. 
 
Inhibitory activity of CNCE 
 
Results from MTT assay showed that CNCE 
exerted a concentration and time-dependent 
inhibitory effects on the growth of human lung 
cancer A549 cells (Table 2). The inhibitory effect 
was highest at a concentration of 320 µg/mL. In 
addition, for each CNCE concentration, the 
inhibitory effect increased with time and became 
maximum at 96 h.  
 
 
Figure 1: Growth curve of A549 human lung cancer 
cells 
 
Table 2: Inhibitory effects of CNCE on A549 lung 




24h 48h 72h 96h 
Control  － － － － － 
CNCE  8 1.28 2.31 2.38 2.48 
CNCE  16 5.36 12.34 19.37 23.31 
CNCE  32 24.47 27.24 35.24 41.24 
CNCE  64 32.24 38.46 49.37 57.33 
CNCE  128 42.12 57.14 68.37 75.46 
CNCE  256 43.14 58.76 70.64 78.25 
 
Effect of CNCE on A549 cell apoptosis and 
cell cycle 
 
CNCE at a concentration of 40 μg/mL brought 
about aCNCEst of cell cycle at G0/G1 phase in 
24 and 48 h, and blocked the transformation from 
G1 phase to S phase (Table 3). With increase in 
G0 - G1 phase transition time, there was 
reduction in the number of cells in the S phase. 
The increases in percentage of cells in the 
G0/G1 phase, and decreases in cells in S phase, 
were concentration-dependent and time-
dependent (p < 0. 01). 
 
Table 3: Effect of CNCE on cell cycle distribution of 
A549 cells at 24 and 48 h 
 
Group G0/G1 (%) S (%) G2/M (%) 
Control  53.42±3.87 42.46±3.34 8.15±1.07 
CNCE 24 h 58.35±3.24* 35.54±4.07* 5.34±1.46* 
CNCE 48 h 63.75±4.34* 23.84±5.46* 3.47±1.28* 
Values are mean ± SEM (n = 8); *p < 0.01 compared 
to control 
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Effect of CNCE on key enzymes of apoptosis 
and protein expression levels of apoptosis-
related genes 
 
Immunocytochemistry results showed that CNCE 
at 40 ug/mL brought about significant increases 
in the expressions of apoptosis-related proteins 
caspase-3, caspase-8 and caspase-9 in 24 h, 
when compared with control (p < 0.01, Table 4).  
 
Table 4: Effect of CNCE on the expressions of 








Control  16.24±3.27 18.16±2.24 27.43±3.24 
CNCE  52.34±4.42* 48.62±4.43* 58.43±5.42* 
Values are expressed as mean ± SEM; *p < 0. 01 
compared with control 
 
Visible light microscopy showed Ki-67 protein 
staining in the nucleus; and BCL-2 and p21 ras 
protein in the cytoplasm. There were more 
positive cells in the control group, but at a 
concentration of 40 μg / mL, there were 
significant decreases in the number of positive 
cells (p < 0. 01). The level of protein expression 
was significantly higher in the CNCE group than 
in the control group (p < 0. 01, Table 5). 
 
Table 5: Effect of CNCE on the expressions of Bcl-2, 
Ki-67 and P21 ras protein 
 
Group Bcl-2 (%) Ki-67 (%) p21 ras (%) 
Control  75.26±6.45 78.43±4.98 54.51±6.12 
CNCE  43.21±4.46* 39.23±5.04* 28.24±4.27* 




The results obtained in this study show that 
CNCE has significant time- and concentration-
dependent inhibitory effects on the proliferation 
of A549 cells. The extract also exerted strong 
apoptotic effects on the A549 cells, as seen from 
the morphological changes in the cells. The 
dynamics of tumor cell proliferation are due to 
loss of control of cell cycle, resulting in 
uncontrolled G1 / S and G2 / M transformations. 
The cells were mainly in the active DNA 
synthesis S phase, which led to abnormal cell 
proliferation [5]. Thus blockage of the G1/S 
phase and G2/M phase can effectively control 
the tumor cell cycle and inhibit tumor 
proliferation.  
 
In this study, results from cell cycle analysis 
showed that CNCE reduced the number of A549 
human lung cancer cells in G1, S and G2/M 
phases, leading to stagnation of the cell cycle 
and restraining of cell proliferation. Increased 
concentrations of aqueous fractions of CNCE 
brought about enhanced effects on cell cycle 
aCNCEst. This indicates that CNCE causes lung 
cancer cell cycle aCNCEst by regulation and 
inhibition of tumor cell mitosis.  
 
Ki-67 antigen is a more positive marker of 
nuclear proliferation, and Ki-67 may be used as a 
biomarker for determining high risk individuals in 
pre-cancer population [7-9]. Results from Ki-67 
antigen assay showed that CNCE significantly 
decreased the expression of Ki-67 in A549 cells. 
This implies that a large number of the A549 
cancer cells were in the stationary phase of cell 
cycle. In effect, CNCE may contain active 
principles that regulate the gene which inhibits 
cancer cell mitosis, thereby inhibiting the growth 
of tumor cells. 
  
P21 ras cancer gene is involved in transmission 
of intracellular information which regulates the 
cell cycle, and it is the "initiation factor" in the 
occuCNCEnce of tumors [10-13]. The expression 
of p21ras antigen was also significantly 
decreased in the CNCE-treated A549 cells, in a 
time- and concentration-dependent manner, 
when compared with untreated controls. Again, 
this is an indication that most of the cancer cells 
were in the S phase of the cell proliferation cycle. 
This supports the presence of anti-proliferative 
and mitosis-inhibiting agents in CNCE. 
 
Caspases are proteolytic enzymes which 
constitute key components of the apoptosis 
system. They are a family of cysteine proteases 
involved in regulation of apoptosis, which is 
considered to be a key to cancer cell death [14–
17]. In this study, CNCE treatment led to 
significantly lowered expression of Bcl-2, and 
significant increases in the expression of 
caspase-9. These results demonstrate that the 
anti-proliferative effects CNCE also involve the 
mitochondrial apoptotic pathway.  
 
Caspase-3 is a pro-apoptosis caspase. Its 
expression in the CNCE-treated A549 human 
lung cancer cells was significantly higher than in 
the untreated control cells, indicating that CNCE 
promotes apoptosis in these cells. Thus, CNCE 
induced apoptosis by inhibiting the signal 
transduction pathway enzymes to achieve 
elevated expressions of the pro-apoptosis 
caspases 3, 8 and 9; as well as the apoptosis-




The findings of this study reveal that CNCE has 
significant effect on the inhibition of proliferation 
and induction of apoptosis in human lung cancer 
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A549 cells. These findings suggest that the plant 
material might be a potent source of drugs for the 
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